CDEK
← All trials

NCT00519298

Phase 1Interventional

Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 1, 2007
Primary completion
Mar 1, 2008
Completion date
Mar 1, 2008
First posted
—
Last posted
—
Enrollment
25
Arms / groups
3 / —
Source
AACT · pre-existing

Sponsors

  • PfizerLead sponsor
  • WyethStudy director
  • WyethOverall official - principal investigator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.